STERIS plc

STE

NYSE

263.28

USD

+2.26(+0.87%)

As of today

Overview Financials Dividends Ratios Discussions Analysis

STERIS plc fundamentals

Overview Income Statement Balance Sheet Cash Flow

Key ratios

P/E Ratio

37.72

Price/Book

3.70

Debt/Equity

1.80%

Return on Equity

10.21%

Dividend Yield

0.91%

EBITDA

1.36B

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

Statements Highlights

AnnualQuarterly

Period Ending	Mar 31, 2021	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025
Total Revenue	3,107,519,000	4,223,403,000	4,536,266,000	5,138,701,000	5,459,515,000
Gross Profit	1,343,100,000	1,883,007,000	1,980,726,000	2,218,160,000	2,402,764,000
Operating Income	548,368,000	477,815,000	791,101,000	836,118,000	866,641,000
Net Income	397,400,000	243,888,000	107,030,000	378,239,000	614,641,000
Total Assets	6,574,471,000	11,423,594,000	10,821,839,000	11,063,697,000	10,146,811,000
Total Current Liabilities	577,920,000	922,222,000	861,844,000	931,127,000	1,022,173,000
Total Equity	3,891,468,000	6,544,637,000	6,087,172,000	6,315,346,000	6,615,757,000
Free Cash Flow	450,378,000	397,248,000	394,978,000	612,948,000	777,996,000
Cash from Operations	689,640,000	684,811,000	756,947,000	973,274,000	1,148,087,000
Cash from Investing	-1,154,159,000	-666,559,000	-383,330,000	-887,361,000	388,773,000
Cash from Financing	345,620,000	115,830,000	-498,718,000	-85,186,000	-1,572,364,000
Net Change in Cash	-99,050,000	127,789,000	-139,963,000	-1,337,000	-35,319,000

STERIS plc

STE

263.28

STERIS plc fundamentals

Key ratios

Statements Highlights

Dividends

Analyst Recomendations